Clinical symptoms of inhalation exposure to formaldehyde (FA) include eye, nose, and upper-respiratory irritation, aggravate pre-existing asthma, and depressed lung function activities (
1,
2). FA is a genotoxic chemical that can cause squamous cancer of the nasal passages and cancer of nasopharyngeal regions (
3). International Agency for Research on Cancer (IARC) classified FA as ‘human carcinogen’ (group 1) (
4). FA is also an endogenous compound produced in cells and excreted through exhaled breath (
5).
The U.S. Occupational Safety Health Administration (OSHA) has established the permissible exposure limit (PEL) for airborne FA at a value of 0.75 parts per million (8 h time-weighted average (TWA)); the short-term (15 min) exposure limit (STEL) is 2 ppm. The National Institute of Occupational Safety and Health (NIOSH) has also presented PEL of 0.016 ppm (8 h TWA) and 0.1 ppm (STEL). American regulating authorities require the individuals having higher exposure to use proper respirators (
6).
Concerns have been raised regarding the health of employees and students exposed to FA in the anatomy laboratories due to the vapors emitted during the dissection of cadavers in producing complaints as: unpleasant odor (68%), cough (64%), sore throat and runny nose (56%), nasal irritation and itching (52%), and eye irritation (48%) (
7). However, the effects of chronic exposure of FA could be more severe than respiratory symptoms and recently higher incidence of amyotrophic lateral sclerosis (ALS) was reported as the result of FA (
8). Occupational monitoring of anatomy laboratory workers to FA in the various university anatomy theaters has been reported to be a health concern; more stringent evaluations and controls in the form of a lateral exhaust ventilation system for the dissection tables and personal protective equipment were requested (
9).
Generally, biological monitoring is an accurate evaluation of occupational exposure to volatile organic compounds (
10). Due to the difficulties and disadvantages of blood and urine sampling, recent approaches for assessing occupational and environmental exposure to several chemicals as well as biological monitoring have focused on exhaled breath (
11,
12). There is no commonly accepted method for biological monitoring for FA (
13). Several factors, including the skin absorption, age-related differences in individual uptake, behaviors of workers, poor personnel work practice, the effectiveness of personal protective equipment (PPE), and the workload will probably influence personal sampling in workplaces. Biological monitoring has been traditionally recommended as the complementary method in the evaluation of the chemical exposures (
14). However, this approach is changing and biological monitoring is recommended for hazardous chemicals as the method of choice for monitoring exposure and health risk assessment (
15). There are several attempts for biological monitoring of FA such as: exploring DNA-protein cross-links in workers exposed to FA (
16) and sister chromatid exchange rate in the personnel with exposure to FA in the range of 0.04 to 6.9 ppm (
17). In clinical monitoring of cancer patients and cigarette smokers, FA was measured in their exhaled breath (
12,
18).
The results of toxicokinetic studies indicated that inhaled FA absorption in humans occurs primarily at the site of entry. The site of absorption of FA from the respiratory tract depends on a number of factors, including airway anatomy, breathing pattern, and ventilation rate (
19). According to some studies, the half-life of circulating FA in the bloodstream, upon the absorption in the respiratory tract is reported about 1 minute (
20). Generally, it is reported that Inhaled FA rapidly biotransforms to formate (
13,
21-
23). Thus, FA, in exhaled breath has been reported in the range of a few parts per billion concentrations, however, the validity of measurement methods was reported questionable (
21).